Skip to main content
. 2012 May 16;2012(5):CD007338. doi: 10.1002/14651858.CD007338.pub3

Comparison 1. Intervention versus control.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Mortality 8   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.1 Low CVP versus control 3 177 Risk Ratio (M‐H, Fixed, 95% CI) 0.36 [0.02, 8.43]
1.2 Autologous blood donation versus control 1 79 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Haemodilution versus control 2 150 Risk Ratio (M‐H, Fixed, 95% CI) 0.35 [0.04, 3.32]
1.4 Haemodilution with controlled hypotension versus control 1 20 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.5 Haemodilution with bovine haemoglobin (HBOC‐201) versus haemodilution with hydroxy ethyl starch (HES) 1 12 Risk Ratio (M‐H, Fixed, 95% CI) 3.0 [0.15, 61.74]
1.6 Hypoventilation versus control 1 79 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Serious adverse events 5   Rate Ratio (Fixed, 95% CI) 0.97 [0.57, 1.65]
2.1 Autologous blood donation versus control 1   Rate Ratio (Fixed, 95% CI) 0.49 [0.04, 5.32]
2.2 Haemodilution versus control 2   Rate Ratio (Fixed, 95% CI) 1.01 [0.57, 1.80]
2.3 Haemodilution with bovine haemoglobin (HBOC‐201) versus haemodilution with hydroxy ethyl starch (HES) 1   Rate Ratio (Fixed, 95% CI) 0.50 [0.05, 5.48]
2.4 Hypoventilation versus control 1   Rate Ratio (Fixed, 95% CI) 1.95 [0.18, 21.35]
3 Adverse events (severity unknown) 4   Rate Ratio (Fixed, 95% CI) 1.12 [0.68, 1.85]
3.1 Low CVP versus control 2   Rate Ratio (Fixed, 95% CI) 0.76 [0.28, 2.03]
3.2 Haemodilution versus control 1   Rate Ratio (Fixed, 95% CI) 1.38 [0.56, 3.39]
3.3 Hypoventilation versus control 1   Rate Ratio (Fixed, 95% CI) 1.22 [0.57, 2.62]
4 Number requiring allogeneic blood transfusion 8   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
4.1 Low CVP versus control 3 177 Risk Ratio (M‐H, Fixed, 95% CI) 0.66 [0.42, 1.03]
4.2 Autologous blood donation versus control 1 79 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 Haemodilution versus control 3 233 Risk Ratio (M‐H, Fixed, 95% CI) 0.41 [0.25, 0.66]
4.4 Haemodilution with controlled hypotension versus control 1 20 Risk Ratio (M‐H, Fixed, 95% CI) 0.05 [0.00, 0.72]
4.5 Hypoventilation versus control 1 79 Risk Ratio (M‐H, Fixed, 95% CI) 0.73 [0.17, 3.06]
5 Red cell transfusion 7   Std. Mean Difference (IV, Fixed, 95% CI) Subtotals only
5.1 Low CVP versus control 2 135 Std. Mean Difference (IV, Fixed, 95% CI) ‐0.31 [‐0.65, 0.03]
5.2 Haemodilution versus control 3 180 Std. Mean Difference (IV, Fixed, 95% CI) ‐0.33 [‐0.63, ‐0.03]
5.3 Haemodilution with controlled hypotension versus control 1 20 Std. Mean Difference (IV, Fixed, 95% CI) ‐3.63 [‐5.16, ‐2.10]
5.4 Haemodilution with bovine haemoglobin (HBOC‐201) versus haemodilution with hydroxy ethyl starch (HES) 1 12 Std. Mean Difference (IV, Fixed, 95% CI) 0.23 [‐0.91, 1.36]
5.5 Hypoventilation versus control 1 80 Std. Mean Difference (IV, Fixed, 95% CI) ‐0.12 [‐0.55, 0.32]
6 Fresh frozen plasma     Other data No numeric data
6.1 Low central venous pressure versus control     Other data No numeric data
7 Operative blood loss (ml) 8   Mean Difference (IV, Fixed, 95% CI) Subtotals only
7.1 Low central venous pressure versus control 3 175 Mean Difference (IV, Fixed, 95% CI) ‐419.35 [‐575.06, ‐263.63]
7.2 Autologous blood donation versus control 1 79 Mean Difference (IV, Fixed, 95% CI) ‐37.0 [‐100.51, 26.51]
7.3 Haemodilution versus control 3 128 Mean Difference (IV, Fixed, 95% CI) ‐17.95 [‐67.89, 32.00]
7.4 Haemodilution with controlled hypotension versus control 1 20 Mean Difference (IV, Fixed, 95% CI) ‐245.00 [‐357.80, ‐136.20]
7.5 Haemodilution with bovine haemoglobin (HBOC‐201) versus haemodilution with hydroxy ethyl starch (HES) 1 12 Mean Difference (IV, Fixed, 95% CI) 370.0 [‐1103.59, 1843.59]
8 Operating time (minutes) 5   Mean Difference (IV, Fixed, 95% CI) Subtotals only
8.1 Low CVP versus control 2 90 Mean Difference (IV, Fixed, 95% CI) ‐24.69 [‐44.28, ‐5.09]
8.2 Haemodilution versus control 2 208 Mean Difference (IV, Fixed, 95% CI) ‐28.86 [‐57.37, ‐0.35]
8.3 Haemodilution with bovine haemoglobin (HBOC‐201) versus haemodilution with hydroxy ethyl starch (HES) 1 12 Mean Difference (IV, Fixed, 95% CI) 23.0 [‐83.60, 129.60]
9 Hospital stay (days) 4   Mean Difference (IV, Fixed, 95% CI) Subtotals only
9.1 Low CVP versus control 2 135 Mean Difference (IV, Fixed, 95% CI) ‐4.53 [‐7.38, ‐1.68]
9.2 Haemodilution versus control 1 130 Mean Difference (IV, Fixed, 95% CI) 0.0 [‐2.66, 2.66]
9.3 Haemodilution with bovine haemoglobin (HBOC‐201) versus haemodilution with hydroxy ethyl starch (HES) 1 12 Mean Difference (IV, Fixed, 95% CI) 2.30 [‐7.52, 12.12]